14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
STN vs MCRI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Monarch Casino & Resort Inc (MCRI) captures the overall head-to-head institutional edge over Stantec, Inc. (STN) on higher Unified Composite conviction (36.7/100 SELL vs. 29.0/100 SELL) after splitting the core matrix 6–4 (led by Profitability & Quality, Balance Sheet & Cash Flow), while STN wins 3–2 across the 6-pillar growth and valuation breakdown. STN trades at $84.04 (12.0x Forward P/E, 12.6% operating margin) versus MCRI at $104.55 (14.9x Forward P/E, 26.9% operating margin).
Growth vs. Quality Trade-Off: MCRI earns the overall head-to-head edge with a stronger Unified Composite Score (36.7/100 SELL vs. STN 29.0/100 SELL) and 0.44β · 28% Vol risk profile, whereas STN leads top-line expansion (+9.4% YoY revenue growth, 1.38x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Defensive Composite Rating Caution: Although MCRI compares more favorably head-to-head, both STN (29.0/100 SELL) and MCRI (36.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: STN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 68.8); meanwhile MCRI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on STN vs MCRI. Trailing 12-month operating profitability (STN 12.6% vs MCRI 26.9%) and valuation multiples (STN 12.0x vs MCRI 14.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Resorts & Casinos value chain with $1.9B market capitalization and 26.9% operating margin.
OpEx & R&D Reinvestment41.1% of Rev ($232M)
90D Engineering Disclosures0 Published
Investor FAQ STN vs MCRI Key Questions & Quantitative Answers
As of Nov 20, 2026, Monarch Casino & Resort Inc (MCRI) captures the overall head-to-head institutional edge over Stantec, Inc. (STN) on higher Unified Composite conviction (36.7/100 SELL vs. 29.0/100 SELL) after splitting the core matrix 6–4 (led by Profitability & Quality, Balance Sheet & Cash Flow), while STN wins 3–2 across the 6-pillar growth and valuation breakdown. STN trades at $84.04 (12.0x Forward P/E, 12.6% operating margin) versus MCRI at $104.55 (14.9x Forward P/E, 26.9% operating margin). Growth vs. Quality Trade-Off: MCRI earns the overall head-to-head edge with a stronger Unified Composite Score (36.7/100 SELL vs. STN 29.0/100 SELL) and 0.44β · 28% Vol risk profile, whereas STN leads top-line expansion (+9.4% YoY revenue growth, 1.38x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although MCRI compares more favorably head-to-head, both STN (29.0/100 SELL) and MCRI (36.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: STN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 68.8); meanwhile MCRI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
STN leads the Growth & Scale pillar: STN posts +9.4% YoY revenue growth and +21.8% YoY earnings growth on $4.90B TTM revenue (54.5% gross margin, 12.6% operating margin), compared with MCRI at +2.4% YoY revenue growth and +4.1% YoY earnings growth on $565M TTM revenue (68.0% gross margin, 26.9% operating margin). On trailing 12-month operating scale, STN generates $4.90B in USD-normalized revenue versus $565M for MCRI. In operating R&D and SG&A reinvestment, STN deploys 41.9% of Rev ($2.05B) (0 90-day corporate R&D disclosures) versus 41.1% of Rev ($232M) (0 disclosures) for MCRI.
STN screens cheaper on headline valuation multiples. STN trades at 12.0x Forward P/E, 24.5x Trailing P/E, 1.38x PEG, and 1.9x EV/Revenue (15.5% EBITDA margin), whereas MCRI trades at 14.9x Forward P/E, 16.9x Trailing P/E, 1.07x PEG, and 3.3x EV/Revenue (34.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against STN (16.2% ROE) versus MCRI (20.4% ROE) capital efficiency.
In options market volatility and institutional positioning, STN carries 24.6% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.38β · 56% Vol realized risk). By comparison, MCRI carries 38.1% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 28% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.